Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer
Immune checkpoint inhibitors are a cornerstone of non–small cell lung cancer treatment. But there is a question that’s been vexing oncologists for years: When can treatment be stopped? A new review of clinical trial data suggests that it is safe to stop immunotherapy after 2 years if the patient is progression-free. There was no difference in overall survival between such […]
Continue reading »